Rowan Cheung's podcast delves into cutting-edge AI advancements, featuring experts discussing AI's potential to cure diseases, the rise of AI agents, the future of work, and AI's role in education, while exploring groundbreaking models and technologies from tech giants like Google, Microsoft, and Meta.
A revolutionary brain implant allows a paralyzed individual to communicate through synthesized speech and singing by capturing neural signals from the speech region of their brain, using AI to decode and reproduce their voice and vocal inflections in real time.
Innovative AI software revolutionizes healthcare access in Brazil's Amazon, quadrupling pharmacists' capacity to process prescriptions while safeguarding against dangerous errors, signaling a potential global solution for overstretched medical systems.
Themis AI, an MIT spinout co-founded by Professor Daniela Rus, has developed Capsa, a platform that can work with any machine learning model to detect and correct unreliable outputs in seconds by quantifying model uncertainty and addressing knowledge gaps.
University Hospitals adopts cutting-edge AI-powered Varian Ethos 2.0 system for precision adaptive radiotherapy, enabling personalized cancer treatment plans and higher radiation doses while minimizing harm to healthy tissue through real-time imaging and motion tracking.
A wall-mounted AI device that scans feet for fluid buildup can predict heart failure hospitalizations an average of 13 days in advance, potentially allowing timely interventions to prevent hospitalization, according to research presented at the British Cardiovascular Society conference.
DeepMind's CEO Hassabis predicts human-level artificial general intelligence (AGI) within a decade, heralding a 'golden era' where AGI solves major global challenges like disease and energy scarcity, though potential risks remain.
Paradromics, a neurotech startup rivaling Elon Musk's Neuralink, successfully implanted and removed its brain-computer interface device during human surgery, marking a major milestone as it prepares for broader clinical trials to help people with severe motor impairments like paralysis.
The FDA's new AI tool for reviewing medical devices, CDRH-GPT, is struggling with basic tasks like uploading documents and accessing recent studies, raising concerns about rushing AI adoption before it's ready to handle complex regulatory work accurately and safely.
Neurotech startup Paradromics has achieved a major milestone by successfully implanting its brain-computer interface in a human for the first time, paving the way for a clinical trial later this year to study the long-term safety and use of its technology.